West Pharmaceutical Services (WST) Inventory Average (2010 - 2026)

West Pharmaceutical Services (WST) has reported Inventory Average for 17 consecutive years, with $450.0 million the latest figure, recorded in Q2 2026.

• Quarterly Inventory Average rose 11.14% year-over-year to $450.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $450.0 million (up 11.14% YoY) and the FY2025 annual result came in at $410.4 million, up 1.13% from the prior year.
• Inventory Average was little changed at $450.0 million in Q2 2026 per WST's latest filing, from $448.2 million in the prior quarter.
• Over the last five years, Inventory Average for WST reached as high as $450.0 million in Q2 2026 and fell as low as $382.8 million in Q1 2025.
• A 5-year average of $422.4 million and a median of $427.0 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average grew 26.35% — and 2025, when it decreased 11.44%.
• Year by year, Inventory Average stood at $414.0 million in 2022, then climbed by 4.66% to $433.2 million in 2023, then decreased by 10.19% to $389.1 million in 2024, then grew by 13.33% to $441.0 million in 2025, then grew by 2.05% to $450.0 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $450.0 million, $448.2 million, and $441.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.